Skip to content

Pershing Edward

Reporting owner on Forms 3, 4 and 5, CIK 1689739.

Pershing Edward reported on 1 issuer in 6 filings, the latest a Form 4 filed 2026-11-16.

Issuers

IssuerRoles in the latest filingFilingsLast filed
PROVECTUS BIOPHARMACEUTICALS, INC. CIK 315545director, officer (CEO), 10% owner62026-11-16

Transactions and holdings

Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.

SecurityDateCodeSharesPriceOwned afterFiling
PVCT · PROVECTUS BIOPHARMACEUTICAL…8% Unsecured Convertible Promissory Note, derivative2026-11-13M exercised-$0Form 4
PVCT · PROVECTUS BIOPHARMACEUTICAL…Series D-1 Convertible Preferred Stock, derivative2026-11-13M exercised+11,328$03,055,221Form 4
PVCT · PROVECTUS BIOPHARMACEUTICAL…8% Unsecured Convertible Promissory Note, derivative2026-11-06M exercised-$0Form 4
PVCT · PROVECTUS BIOPHARMACEUTICAL…Series D-1 Convertible Preferred Stock, derivative2026-11-06M exercised+13,216$03,043,893Form 4
PVCT · PROVECTUS BIOPHARMACEUTICAL…8% Unsecured Convertible Promissory Note, derivative2026-10-30M exercised-$0Form 4
PVCT · PROVECTUS BIOPHARMACEUTICAL…Series D-1 Convertible Preferred Stock, derivative2026-10-30M exercised+24,544$03,030,677Form 4
PROVECTUS BIOPHARMACEUTICAL… 8% Unsecured Convertible Promissory Note, derivative2026-10-23M exercised-$0Form 4
PROVECTUS BIOPHARMACEUTICAL… Series D-1 Convertible Preferred Stock, derivative2026-10-23M exercised+7,599$03,006,133Form 4
PROVECTUS BIOPHARMACEUTICAL… 8% Unsecured Convertible Promissory Note, derivative2026-10-10M exercised-$0Form 4
PROVECTUS BIOPHARMACEUTICAL… Series D-1 Convertible Preferred Stock, derivative2026-10-10M exercised+22,609$02,998,534Form 4
PROVECTUS BIOPHARMACEUTICAL… 8% Unsecured Convertible Promissory Note, derivative2026-10-03M exercised-$0Form 4
PROVECTUS BIOPHARMACEUTICAL… Series D-1 Convertible Preferred Stock, derivative2026-10-03M exercised+13,216$02,975,925Form 4

Filings

The person's Forms 3, 4 and 5, and any 13D or 13G naming it.

FilingSubjectFiledAcceptedIngested
Form 4 0001493152-26-052537 PROVECTUS BIOPHARMACEUTICALS, INC.2026-11-16
Form 4 0001493152-26-050663 PROVECTUS BIOPHARMACEUTICALS, INC.2026-11-09
Form 4 0001493152-26-049383 PROVECTUS BIOPHARMACEUTICALS, INC.2026-10-30
Form 4 0001493152-26-048321 PROVECTUS BIOPHARMACEUTICALS, INC.2026-10-23
Form 4 0001493152-26-046701 PROVECTUS BIOPHARMACEUTICALS, INC.2026-10-13
Form 4 0001493152-26-045713 PROVECTUS BIOPHARMACEUTICALS, INC.2026-10-05